Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study

International Journal of Cardiology

Volumn 196, Issue , 2015, Pages 91-97

  Chao, Tze Fan ^a,b   Liu, Chia Jen ^a,b   Chen, Su Jung ^a,b   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Chen, Tzeng Ji ^a   Lip, Gregory Y H ^c   Chiang, Chern En ^a,b   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Dementia; Statin

Indexed keywords

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; ROSUVASTATIN;

AGED; ARTICLE; ATRIAL FIBRILLATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HEART PROTECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; TAIWAN; TREATMENT DURATION; COHORT ANALYSIS; FACTUAL DATABASE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; DATABASES, FACTUAL; DEMENTIA; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PROPENSITY SCORE; RISK FACTORS; TIME FACTORS;

EID: 84937416416     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.05.159     Document Type: Article

References (33)

1. G.V. Naccarelli, H. Varker, J. Lin, and K.L. Schulman Increasing prevalence of atrial fibrillation and flutter in the United States Am. J. Cardiol. 104 2009 1534 1539
2. S. Dublin, M.L. Anderson, S.J. Haneuse, and et al. Atrial fibrillation and risk of dementia: a prospective cohort study J. Am. Geriatr. Soc. 59 2011 1369 1375
3. T.S. Potpara, and G.Y. Lip Lone atrial fibrillation: what is known and what is to come Int. J. Clin. Pract. 65 2011 446 457
4. H.F. Tse, Y.J. Wang, M. Ahmed Ai-Abdullah, and et al. Stroke prevention in atrial fibrillation - an Asian stroke perspective Heart Rhythm. 10 2013 1082 1088
5. T.J. Bunch, J.P. Weiss, B.G. Crandall, and et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia Heart Rhythm. 7 2010 433 437
6. I. Marzona, M. O'Donnell, K. Teo, and et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies CMAJ 184 2012 E329 E336
7. P. Santangeli, L. Di Biase, R. Bai, and et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis Heart Rhythm. 9 2012 1761 1768
8. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors Arch. Neurol. 57 2000 1439 1443
9. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
10. Heart Protection Study Collaborative G MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
11. E.G. Rodriguez, H.H. Dodge, M.A. Birzescu, G.P. Stoehr, and M. Ganguli Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study J. Am. Geriatr. Soc. 50 2002 1852 1856
12. P.P. Zandi, D.L. Sparks, A.S. Khachaturian, and et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study Arch. Gen. Psychiatry 62 2005 217 224
13. T.D. Rea, J.C. Breitner, B.M. Psaty, and et al. Statin use and the risk of incident dementia: the Cardiovascular Health study Arch. Neurol. 62 2005 1047 1051
14. K.J. Swiger, R.J. Manalac, R.S. Blumenthal, M.J. Blaha, and S.S. Martin Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects Mayo Clin. Proc. 88 2013 1213 1221
15. S.J. Chen, C.J. Liu, T.F. Chao, and et al. Dental scaling and atrial fibrillation: a nationwide cohort study Int. J. Cardiol. 168 2013 2300 2303
16. L.J. Lin, M.H. Cheng, C.H. Lee, D.C. Wung, C.L. Cheng, and Y.H. Kao Yang Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation - a nationwide descriptive study in Taiwan Clin. Ther. 30 2008 1726 1736
17. C.H. Chang, Y.C. Lee, C.T. Tsai, and et al. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease Atherosclerosis 232 2014 224 230
18. P.L. Chen, W.J. Lee, W.Z. Sun, Y.J. Oyang, and J.L. Fuh Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study PLoS One 7 2012 e49113
19. R.J. Caselli Current issues in the diagnosis and management of dementia Semin. Neurol. 23 2003 231 240
20. J.C. Morris Dementia update 2003 Alzheimer Dis. Assoc. Disord. 17 2003 245 258
21. R.A. Whitmer, S. Sidney, J. Selby, S.C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2005 277 281
22. M.T. Schram, S.M. Euser, A.J. de Craen, and et al. Systemic markers of inflammation and cognitive decline in old age J. Am. Geriatr. Soc. 55 2007 708 716
23. S. Trompet, P. van Vliet, A.J. de Craen, and et al. Pravastatin and cognitive function in the elderly. Results of the PROSPER study J. Neurol. 257 2010 85 90
24. A.E. Roher, C. Esh, T.A. Kokjohn, and et al. Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease Arterioscler. Thromb. Vasc. Biol. 23 2003 2055 2062
25. M. Yarchoan, S.X. Xie, M.A. Kling, and et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias Brain 135 2012 3749 3756
26. M.A. Albert, E. Danielson, N. Rifai, and P.M. Ridker Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70
27. P. Komulainen, T.A. Lakka, M. Kivipelto, and et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women Age Ageing 36 2007 443 448
28. G. Xu, Z. Zhou, W. Zhu, X. Fan, and X. Liu Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment J. Neurol. Sci. 284 2009 77 80
29. H. Wersching, T. Duning, H. Lohmann, and et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function Neurology 74 2010 1022 1029
30. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J. Am. Coll. Cardiol. 50 2007 2021 2028
31. Y. Guo, G.Y. Lip, and S. Apostolakis Inflammation in atrial fibrillation J. Am. Coll. Cardiol. 60 2012 2263 2270
32. S. Vuletic, R.G. Riekse, S.M. Marcovina, E.R. Peskind, W.R. Hazzard, and J.J. Albers Statins of different brain penetrability differentially affect CSF PLTP activity Dement. Geriatr. Cogn. Disord. 22 2006 392 398
33. W. Dong, S. Vuletic, and J.J. Albers Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells J. Lipid Res. 50 2009 2095 2102